Global Eyelash Serum Market Set to Reach USD 1,228.4 Million by 2028, Witnessing An Incremental CAGR Of 6.6% | Growth Market Reports

2021-12-27 07:15:20 By : Owen Shen

PUNE, India , Dec. 23, 2021 /PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Global Eyelash Serum Market by Types (Lash Primer, Formulas Containing Prostaglandins, and Serums Containing Peptides), Price Range (Below USD 50 , USD 51 to 100, and More Than USD 100 ), Distribution Channels (Supermarkets/Hypermarkets, Specialty Stores, Independent Retailers, and Online Sales), and Regions: Size, Share, Trends and Opportunity Analysis, 2018-2028", the market was valued at USD 746.7 Million in 2020 and is expected to grow at a healthy growth rate of 6.6% by the year 2028. The global eyelash serum market is projected to expand at a rapid pace, due to rising demand for eyelash serum in various industries, majorly in fashion, entertainment, cosmetics, and beauty.

Key Market Players Profiled in the Report

Athena Cosmetics, Inc (RevitaLash Cosmetics)

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Download PDF Sample here: https://growthmarketreports.com/request-sample/2627

This report also includes a complete analysis of industry players that cover their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping them to expand their market share.

Highlights on the segments of the Eyelash Serum Market

In terms of types, the global Eyelash Serum market is segmented into lash primer, formulas containing prostaglandins, and serums containing peptides. The lash primer segment is expected to hold a significant share of the market and is anticipated to expand at a considerable CAGR during the forecast period, as it has several benefits. It helps to separate the lashes and coat mascara evenly on lashes. Primer gives extra volume to the lashes, which makes it look fuller and thicker.

On the basis of price range, the global eyelash serum market is segmented into below USD 50 , USD 51 to 100, and more than USD 100 . The below USD 50 segment is estimated to grow at a rapid pace during the forecast period, due to availability of various types of eyelash serums and affordability of the products. Eyelash serums in the pricing range of below USD 50 are largely preferred by individual consumers, which is anticipated to boost the segment.

Based on distribution channels, the global eyelash serum market is segmented into supermarkets/hypermarkets, specialty stores, independent retailers, and online sales. The online segment accounts for a major share of the market and is anticipated to expand at a high CAGR during the forecast period. Online channels offer various advantages such as availability of large number of products, easy return policy, and various deals and discounts, which is projected to boost the market in the coming years.

Based on regions, the global eyelash serum market is fragmented into North America , Europe , Asia Pacific , Latin America , and Middle East & Africa . Europe is the largest eyelash serums market, followed by North America and Asia Pacific . North America is segmented into countries such as the US and Canada . The eyelash serum market in Europe is expanding and dominating as compared to other regional markets, owing to the rising adoption of eyelash serum by several types of customers and consumers including those working in theatres and shows, make-up artists, for individual use, and others. High demand for lash serums and growing application of eyelash serums among consumers in developing countries such as the India and China are expected to boost the global eyelash serum market.

To Buy the Complete Report: https://growthmarketreports.com/report/eyelash-serum-market-global-industry-analysis

Key Takeaways from the Study:

The eyelash serum market in North America is expected to grow fast as compared to European markets, owing to the rising adoption of eyelash serum by several types of customers and consumers including those working in theatres and shows, make-up artists, for individual use, and others.

The Eyelash Serum market in Europe is anticipated to hold major share during the forecast period owing to the technological advancements and well-developed fashion industry in Milan and Paris .

The Eyelash Serum market in Asia Pacific is expected to grow significantly during the forecast period owing to rising disposable income and increasing cosmetic sectors in the region.

The lash primer segment is expected to hold a considerable share of the market during the forecast period, owing to its advantages such as voluminous lashes offered by lash primers. Moreover, easy availability and rising use of lash primers in several industries are fueling the segment.

Online distribution channels use electronic media for buying or selling of goods and services to customers. The online segment is anticipated to boost the market, due to its increasing adoption by people along with its various benefits such as easy return policy and availability of large number of products.

The USD 51 to 100 segment is anticipated to constitute a major market share over the forecast period, due to the rising preference of consumers for eyelash serums in this price range, as it is pocket-friendly.

Read 180 Pages Research Report with Detailed ToC on "Global Eyelash Serum Market by Types (Lash Primer, Formulas Containing Prostaglandins, and Serums Containing Peptides), Price Range (Below USD 50 , USD 51 to 100, and More Than USD 100 ), Distribution Channels (Supermarkets/Hypermarkets, Specialty Stores, Independent Retailers, and Online Sales), and Regions (North America , Latin America , Europe , Asia Pacific , and Middle East & Africa ) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028"

For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/2627

Middle East & Africa (MEA)

Global Eye Care Products Market by Types (Artificial Tear Drops, Ointments or Emollients, Eye Washes, Hyperosmotic, Eyelid Scrubs, Decongestants, and Antihistamines), Sales Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and Regions (North America , Latin America , Europe , Asia Pacific and Middle East & Africa )

Natural Makeup Market by Types (Natural Skincare, Foundations, Lipsticks and Mascara) Applications (Daily Use and Performing Use), and Regions (North America , Europe , Asia Pacific , Latin America , and Middle East & Africa ) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

Global Eyelash Growth Liquid Market by Type (Biotechnology, Natural botanical ingredients, Herbal medicine ingredients), By Application (Young Man with Sparse Eyelashes, Middle and Old Aged) And By Region (North America , Latin America , Europe , Asia Pacific and Middle East & Africa ), Forecast To 2028

Global Eye Makeup Sales Market by Type (Eyeshadow, Eyeliner, False Lashes, Others), By Application (Supermarket, Specialty Retailers, Online, Others) and Region (North America , Latin America , Europe , Asia Pacific and Middle East & Africa ), Forecast To 2028

Growth Market Reports provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Industry Intelligence Solutions". Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys.

Alex Mathews 1st Floor, Kalpavruksha Office No 1, GK Lane Number 3, Ingawale Nagar, Pimple Nilakh, Pune , Maharashtra 411027 Phone: +1 909 414 1393 Email: sales@growthmarketreports.com Web: https://growthmarketreports.com

View original content:https://www.prnewswire.com/news-releases/global-eyelash-serum-market-set-to-reach-usd-1-228-4-million-by-2028--witnessing-an-incremental-cagr-of-6-6--growth-market-reports-301450356.html

Dow Jones futures tilted higher Sunday night, along with S&P 500 futures and Nasdaq futures. The stock market rally revived last week, with the S&P 500 nearly at a new high while a diverse list of leaders flashed buy signals, including AMD stock and Google parent Alphabet.

Naren Gupta, a venture capitalist who co-founded Nexus Venture Partners to help plant Indian SaaS startups on the world map, died on Saturday. Gupta, who moved to the U.S. to pursue higher education in late 1960s, co-founded Integrated Systems, a software firm that was ultimately sold to Intel. After leaving the firm, he began to explore investment opportunities.

When looking for investment ideas for 2022, it pays to look at those stocks that have beaten the market in 2021. Savvy investors know that winners tend to keep on winning, so picking stocks that are already in the market-beating category can increase your odds of investing success.

(Bloomberg) -- Asian stocks were mixed and U.S. equity futures were steady Monday amid a mood of caution as traders evaluated spiking coronavirus cases and a weekend pledge of greater economic support from China’s central bank.Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateU.S. Futures Rise as Traders Mull Virus, China Vow: Markets WrapChina Reports Most Daily Local Infection Cases Since JanuaryWorld E

For retail investors, seeking solid clues to the probable movements of the equity markets, the great volume of published analysis from the Wall Street experts is a blessing, making available everything the investor needs to know to trade successfully. But it comes with a price. The sheer quantity of data involved is almost impossible for the non-expert to parse, but how to know which of the 7,700 stock pros is the best to listen to? A look at the Top Wall Street Analysts ratings from TipRanks ca

Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?

The company, which is sparing its executives from the cut, says it brings benefits in line with what other firms offer. One retiree: ‘If there isn’t a legal obligation, there certainly is a moral obligation.’

SAND and MANA are two of the leading projects in the metaverse space at the moment, and their positive momentum could extend into the coming year.

The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.

Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? JD.com , Nio, Li Auto, Xpeng and BYD Co.. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity.

Abbott Laboratories (NYSE: ABT) shares have gained around 26% in 2021. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.

Wall Street's consensus price target for Teladoc Health (NYSE: TDOC) stock over the next 12 months reflects a 67% upside potential. It's quite possible that the spread of the omicron variant of COVID-19 could give Teladoc a boost in the near term. Teladoc enjoyed a big surge in virtual visits in 2020 thanks to the pandemic.

Will SPY continue the bull run in 2022 after the FED announced it will accelerate the reduction of its monthly bond purchases?

Boeing recorded 109 737 Max orders in November and some 767 freighter orders in December. Is Boeing stock a good buy now?

(Bloomberg) -- The head of Norway’s $1.4 trillion wealth fund said he expects a lengthy period of weakness in financial markets and warned that inflation could be the most significant challenge ahead.Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateU.S. Futures Rise as Traders Mull Virus, China Vow: Markets WrapChina Reports Most Daily Local Infection Cases Since JanuaryWorld Economy Now Set to Surpass $

It's been a wild year for technology stocks. Volatility has been the name of the game, but the tech sector remains one of the best starting points for investors seeking explosive long-term gains. To help provide some investing ideas that can position you to thrive next year, a panel of Motley Fool contributors has profiled three top tech companies that look primed to deliver big wins.

There's no denying that 2021 has been a rough year for many biotech stocks. The shares of quite a few big and small biotech companies alike are set to finish the year in negative territory. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novartis (NYSE: NVS), and Vertex Pharmaceuticals (NASDAQ: VRTX).

2021 was a mixed bag for the renewable energy industry, but investors should stay focused on the companies in this space that have what it takes to be winners over the long haul.

Two stocks that are absurdly cheap right now are Enbridge (NYSE: ENB) and Medical Properties Trust (NYSE: MPW). Canadian energy infrastructure giant Enbridge recently updated its long-term outlook. The company expects to grow its cash flow per share by 10% in 2022 to a range of 5.20 to 5.50 Canadian dollars ($4.03-$4.27).

As traders return from last week's holiday-shortened week, the price action heading into the new year will be closely monitored, especially given the relatively light economic data and earnings calendar for the coming days.